THBD and Sepsis: Biomarkers of endothelial dysfunction are not recommended for routine laboratory investigations in pediatric sepsis, and few studies have examined the role of serum thrombomodulin as a biomarker to predict the clinical course of different sepsis syndromes, sepsis-induced DIC, MODS and mortality in children.